MQS Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Buy
+809
New +$300K 0.38% 118
2024
Q4
Sell
-1,108
Closed -$576K 137
2024
Q3
$576K Buy
1,108
+707
+176% +$378K 0.32% 96
2024
Q2
$217K Buy
+401
New +$212K 0.13% 344
2023
Q4
Sell
-2,639
Closed -$1.15M 511
2023
Q3
$1.15M Buy
2,639
+1,712
+185% +$777K 0.7% 6
2023
Q2
$412K Buy
927
+217
+31% +$100K 0.28% 127
2023
Q1
$326K Buy
+710
New +$338K 0.21% 215
2022
Q4
Sell
-760
Closed -$345K 426
2022
Q3
$345K Sell
760
-818
-52% -$391K 0.22% 178
2022
Q2
$762K Buy
+1,578
New +$781K 0.52% 26

Other funds holding ELV

MQS Management's ELV Position: Q2 2026 in Review

MQS Management opened a new position in Elevance Health (ELV) in Q2 2026: 809 shares worth $313K. The stake represents 0.38% of the portfolio and ranks #118 among its holdings. This is a return to the name: MQS Management previously reported a position in ELV as recently as Q3 2024.

MQS Management first reported a position in ELV in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.15M in Q3 2023. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • MQS Management held 809 shares of Elevance Health worth $313K as of Q2 2026.
  • Elevance Health was a new MQS Management position in Q2 2026.
  • Elevance Health made up 0.38% of MQS Management's portfolio in Q2 2026, its #118 holding.
  • MQS Management first reported a position in Elevance Health in Q2 2022 and has held it in 8 quarters since.
  • MQS Management's Elevance Health position peaked at $1.15M in Q3 2023.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.